RT Journal Article
SR Electronic
T1 Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 3291
OP 3294
VO 37
IS 6
A1 PEPE, PIETRO
A1 GARUFI, ANTONIO
A1 PRIOLO, GIAN DOMENICO
A1 PENNISI, MICHELE
YR 2017
UL http://ar.iiarjournals.org/content/37/6/3291.abstract
AB Background/Aim: To evaluate the detection rate for clinically-significant prostate cancer (PCa) of transperineal (TP) vs. transrectal (TR) multiparametric MRI/TRUS (magnetic resonance imaging/transrectal ultrasound) fusion targeted-biopsy. Patients and Methods: From January 2016 to December 2016, 150 men underwent repeat saturation transperineal prostate biopsy (SPBx; median 30 cores) combined with targeted mpMRI/TRUS TR and TP fusion biopsies (4 cores for each procedure) of suspicious MRI lesions (PI-RADS 3/5). Results: Overall, in 55/150 (36.6%) men a clinically-significant PCa was found and in 49 (89.1%) of them mpMRI was positive. SPBx, mpMRI/TRUS TR and TP fusion targeted-biopsy diagnosed 52 (94.5%), 43 (78.1%) and 49 (89.1%) PCa, respectively; TR fusion biopsy missed 8 (53.3%) while TP missed 2 (13.3%) cancers of the anterior zone. Conclusion: Multiparametric MRI/TRUS TP in comparison to TR fusion biopsy detected a greater percentage of small but clinically significant PCa of the anterior zone (86.7% vs. 46.7%; p=0.0001).